Hide Board Information

Show Board Information

CytoDyn Inc CYDY

Board Mod: HHIGambler

Asst Mods: Riztheinvestor CaptnAmerca mightycydy

Last Post: 12/26/2024 12:53:13 PM

Board Marks: 388

Posts Today: 2

Board Views Today: 16942

CytoDyn Inc. (OTCQB: CYDY)

Company Website: http://www.cytodyn.com/

CytoDyn Inc (OTCMRKTS: CYDY) Stock Message Board

1. CYDY Company Profile

    

2. CYDY Time & Sales

    

3. CYDY Recent News

    

4. CYDY Filings

    

5. CYDY Financials

    

6. CYDY Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

13623	Leronlimab (Pro 140) Cliff Notes What is it? (37)	trding	12/24/2019 8:09:27 PM
112006	Leronlimab - Disease List (currently 90) (updated (28)	ohm20	12/09/2021 8:15:12 AM
144440	Leronlimab Regulator List (a work in progress) = (18)	ohm20	06/12/2024 7:33:56 PM
145805	Here's some basics on the science - Leronlimab (44)	ohm20	08/21/2024 12:48:53 PM
70959	Ya he's overly optimistic. But I'll take that (2)	CDiddy	01/02/2021 6:56:55 PM
70958	I never said they did I said that doctor L has	Shelly2626	01/02/2021 6:56:00 PM
70957	Im definitely going with Dr Jay over Craig. (2)	chazzledazzle	01/02/2021 6:54:27 PM
70956	Absolutely he does ! Either way, we will not know	Riztheinvestor	01/02/2021 6:53:56 PM
70955	I 100% agree with you, CDiddy, but wasn't the (1)	craigakess	01/02/2021 6:53:39 PM
70954	345 refers to the ratio of the length of each	CDiddy	01/02/2021 6:51:39 PM
70953	He certainly has access to the data from EIND. (11)	CDiddy	01/02/2021 6:50:03 PM
70952	Jeez I shouldnt have shared it lol I was just (2)	Riztheinvestor	01/02/2021 6:48:08 PM
70951	CDiddy...that is my point, they do NOT have (1)	craigakess	01/02/2021 6:46:49 PM
70949	Philippines EUA prediction... January 4th is my (2)	Goosebumps	01/02/2021 6:42:33 PM
70948	Your conviction is misguided. The officers of (7)	CDiddy	01/02/2021 6:42:22 PM
70945	Not talking about cd12 data Do more due diligence (2)	Shelly2626	01/02/2021 6:25:26 PM
70944	The 1 and 2 are the non-right angles. I	chazzledazzle	01/02/2021 6:19:50 PM
70943	Whether he has "been around" 1 day or 100 years (1)	craigakess	01/02/2021 6:15:07 PM
70942	I disagree Jay does more than us Been Round lot (2)	Shelly2626	01/02/2021 6:11:27 PM
70941	Thanks. Here's the JAMA article referred to:	lorbas	01/02/2021 6:08:39 PM
70940	Ah my handle. Well, if you remember the (2)	pythagoras345	01/02/2021 6:08:33 PM
70939	Really? You think he'd just reappear on (5)	ClosetInvestor	01/02/2021 6:00:00 PM
70938	This maybe of interest to our members:	MD VIROLOGIST	01/02/2021 5:46:01 PM
70937	If I were going to infer anything else into Dr (1)	chazzledazzle	01/02/2021 5:35:39 PM
70936	You are not wrong. (1)	MD VIROLOGIST	01/02/2021 5:25:19 PM
70935	Not sure as well maybe someone else like Tech	Riztheinvestor	01/02/2021 5:23:17 PM
70934	Yea I think maybe Dr Jay is just making a	Riztheinvestor	01/02/2021 5:21:38 PM
70933	How can you say I am not a MD? How can you say I (5)	MD VIROLOGIST	01/02/2021 5:21:25 PM
70932	To the best of my knowledge, he has nothing to do (1)	craigakess	01/02/2021 5:20:48 PM
70931	Good point but doesnt he see some of the data	Riztheinvestor	01/02/2021 5:19:46 PM
70930	Thank you for your generous offer, but I must (3)	craigakess	01/02/2021 5:19:34 PM
70929	Two things. Craigs adds a realistic bent to (1)	chazzledazzle	01/02/2021 5:18:55 PM
70928	I never said you did either, thats why it was	Riztheinvestor	01/02/2021 5:17:49 PM
70926	Easy there, Stinky. If you think Lalezari knows (3)	craigakess	01/02/2021 5:13:31 PM
70925	I enjoy your cut to the chase observations, at (2)	MD VIROLOGIST	01/02/2021 5:12:29 PM
70922	CD-10 was a discovery phase 2 trial completely (2)	onestepahead	01/02/2021 4:57:18 PM
70920	"Accrued liabilities" is not a play on words. And (2)	craigakess	01/02/2021 4:41:01 PM
70919	Wait...what? I NEVER said, hinted, etc., that I (1)	craigakess	01/02/2021 4:36:51 PM
70917	Here is an opinion piece on the use of all cause (3)	MD VIROLOGIST	01/02/2021 3:27:29 PM
70916	I will try to have empathy for the people who (2)	Riztheinvestor	01/02/2021 3:20:03 PM
70912	345 is part of the pythagorean	CDiddy	01/02/2021 3:10:42 PM
70911	I HIGHLY doubt that. It's just a wish, a hope,	craigakess	01/02/2021 3:06:29 PM
70909	True, so you think he has information ? Maybe	Riztheinvestor	01/02/2021 3:03:28 PM
70908	They also thought they had "other relevant"	Shelly2626	01/02/2021 3:03:04 PM
70906	He has seen many results of Leronlimab with (1)	Shelly2626	01/02/2021 2:59:05 PM
70904	"Accrued Liabilities"..is such an interesting	sean007	01/02/2021 2:52:37 PM
70903	Sounds like Dr. Lalezari knows something we (1)	StinkyPennies	01/02/2021 2:52:11 PM
70902	Were still working on 1 of III in this (5)	pythagoras345	01/02/2021 2:20:00 PM
70901	The CD12 results are coming soon now... The big (1)	Werner	01/02/2021 2:17:07 PM
70900	While it's certainly nice to see that tweet and (3)	craigakess	01/02/2021 2:16:26 PM
70899	To all the folks who hung in there with CytoDyn	Riztheinvestor	01/02/2021 2:11:27 PM
70897	https://twitter.com/drjay62817871/status/13454242 (1)	Riztheinvestor	01/02/2021 2:07:43 PM
70896	Well said this unreal.	Riztheinvestor	01/02/2021 2:01:54 PM
70894	100% agree with your	sean007	01/02/2021 1:53:53 PM

Newer

Older

Recent Articles

• Intelagen Strengthens Web3 Division with New Leadership Hire
• Ryde Group Ltd. Celebrates License Renewal and Stock Surge
• Investors Taking Action Against Celsius Holdings, Inc. Possible Outcomes
• Cardone Capital's Groundbreaking Real Estate-Bitcoin Fund
• Revolutionary Glaucoma Treatment Introduced by Local Doctor
• A Tribute to Manmohan Singh: Legacy of India’s Resilient Leader
• Floki Set to Challenge Dogecoin with New ETP Launch
• Navigating Medical Malpractice Claims with Jason Turchin
• DMC Global Investors: Join the Fight for Justice Now
• Peru Faces Environmental Crisis Amid Oil Spill Disaster
• Lichen China Limited Engages Investors for $2.8 Million Offering
• Freddie Mac's 2024 Designations for STACR Debt Notes Explained
• Is the Proposed Frontier Communications Merger Fairly Priced?
• Chinese EV Stocks Surge as Sales Projections Look Promising
• Investors' Strategies Signal Potential Changes for VST
• Market Whales Signal Confidence in Robinhood Options Trading
• Rocket Lab USA: Exploring Recent Options Trading Dynamics
• Lichen China Limited Secures $2.8 Million in Direct Offering
• Entergy New Orleans Pref Stock Reaches 52-Week Low
• Quantum Corp Reaches New Heights with Stock Surge and Innovations
• Icahn Enterprises Faces Market Pressure with Record Low Stock
• Syndax Pharmaceuticals (NASDAQ: SNDX) Faces Market Challenges
• Understanding Big Money Moves on Deere: Trade Insights
• Analyzing Recent Trading Trends for Honeywell International
• Exploring AST SpaceMobile's Options Activity Surge and Insights
• Class Action Alert: Investors Urged to Act on Sun Communities Case
• Dan Loeb Strengthens Portfolio with ICE and CRH Investments
• Important Notice for Aehr Test Systems Investors: Act Now
• Exploring Trump's Impact on Cannabis Policy Reform
• Evaluating the Viability of Donald Trump's Bitcoin Strategy
• Mobile Crushers and Screeners Market: Insights and Growth Trends
• Understanding Recent Trends in Sony Gr's Short Interest
• Insights into KKR's Rising Short Interest in the Market
• Market Dynamics: Unpacking PG&E's Short Interest Trends
• Key Insights on MGP Ingredients Class Action Lawsuit Timeline
• Investors of Humacyte, Inc. Can Join Class Action for Recovery
• Legal Action Invokes Community Spirit for Flux Investors
• Join the TMC Metals Company Inc. Securities Class Action Now
• Challenges Loom for Ukrainian Gas Transit Amidst Tensions
• SES AI Experiences Unprecedented Stock Surge in One Day
• ModivCare Faces Market Pressures: Analyzing Recent Developments
• LifeVantage Achieves Significant Milestone with Stock Surge
• LPL Financial Holdings Achieves Historic Growth with Stock Surge
• Exciting Developments in Solar Energy by Voltalia in France
• Exploring AI and Health Economics at J.P. Morgan Healthcare
• Odyssey Marine Exploration Partners for Sustainable Fertilizer
• Investors Need to Act Now in Class Action Against MGPI
• Analysts Anticipate Positive Earnings for AAR Corp. Soon
• Milan Markets Face Declines Amid Sector Losses and Oil Prices
• Exploring Options Trades with Stanley Druckenmiller's Insights